Literature DB >> 19502025

Case report: postoperative analgesia and preserved motor function with clonidine and buprenorphine via a sciatic perineural catheter.

David J Whiting1, Brian A Williams, Steven L Orebaugh, Revathi R Toshok.   

Abstract

Two cases of posterolateral corner reconstruction of the knee with postoperative sciatic perineural analgesia using a mixture of clonidine and buprenorphine, are presented. Numeric rating scores for pain with movement were 0-2 out of 10 postoperatively after injection. Gross motor function below the knee was maintained in both cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502025     DOI: 10.1016/j.jclinane.2008.08.027

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  4 in total

1.  Effect of adjuvant drugs on the action of local anesthetics in isolated rat sciatic nerves.

Authors:  Eser Yilmaz-Rastoder; Michael S Gold; Karen A Hough; G F Gebhart; Brian A Williams
Journal:  Reg Anesth Pain Med       Date:  2012 Jul-Aug       Impact factor: 6.288

2.  Toward a potential paradigm shift for the clinical care of diabetic patients requiring perineural analgesia: strategies for using the diabetic rodent model.

Authors:  Brian A Williams
Journal:  Reg Anesth Pain Med       Date:  2010 Jul-Aug       Impact factor: 6.288

3.  Forecast for perineural analgesia procedures for ambulatory surgery of the knee, foot, and ankle: applying patient-centered paradigm shifts.

Authors:  Brian A Williams
Journal:  Int Anesthesiol Clin       Date:  2012

4.  Buprenorphine, Clonidine, Dexamethasone, and Ropivacaine for Interscalene Nerve Blockade: A Prospective, Randomized, Blinded, Ropivacaine Dose-Response Study.

Authors:  Jacques T YaDeau; Michael A Gordon; Enrique A Goytizolo; Yi Lin; Kara G Fields; Amanda K Goon; Guilherme Holck; Timothy W Miu; Lawrence V Gulotta; David M Dines; Edward V Craig
Journal:  Pain Med       Date:  2015-12-14       Impact factor: 3.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.